-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Summary: NewAmsterdam Pharma Co Q4

Benzinga·02/18/2026 14:22:08
Listen to the news

NewAmsterdam Pharma Co (NASDAQ:NAMS) announced its Q4 earnings on Wednesday, February 18, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

NewAmsterdam Pharma Co missed estimated earnings by -65.79%, reporting an EPS of $-0.63 versus an estimate of $-0.38.

Revenue was down $8.60 million from the same period last year.

Performance in Previous Earnings

In the previous quarter, the company missed on EPS by $0.25, resulting in a 2.82% drop change in the share price the following day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for NewAmsterdam Pharma Co visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.